IGF1 and metabolic disease: Recently, as the incidence of dementia accompanying metabolic disorders increases, the interest in the effects of IGF-1, which exhibits various ameliorating effects in metabolic disorders, on the central nervous system (CNS) is increasing [34,35,36].